1. Home
  2. POCI vs ELUT Comparison

POCI vs ELUT Comparison

Compare POCI & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

HOLD

Current Price

$4.39

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$0.94

Market Cap

42.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POCI
ELUT
Founded
1982
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.5M
42.5M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
POCI
ELUT
Price
$4.39
$0.94
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
39.5K
54.9K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.77
EPS
N/A
N/A
Revenue
$19,091,269.00
$12,293,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$0.50
52 Week High
$6.15
$2.50

Technical Indicators

Market Signals
Indicator
POCI
ELUT
Relative Strength Index (RSI) 44.33 54.68
Support Level $4.00 $0.86
Resistance Level $4.65 $1.00
Average True Range (ATR) 0.27 0.07
MACD 0.03 0.00
Stochastic Oscillator 44.31 96.00

Price Performance

Historical Comparison
POCI
ELUT

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

Share on Social Networks: